title: Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor.
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Zesiewicz
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Sullivan
authors.forename: Vanessa
authors.initials: V
authors.lastname: Hinson
authors.forename: Natividad P
authors.initials: NP
authors.lastname: Stover
authors.forename: John
authors.initials: J
authors.lastname: Fang
authors.forename: Israt
authors.initials: I
authors.lastname: Jahan
authors.forename: Amber
authors.initials: A
authors.lastname: Miller
authors.forename: Michael A
authors.initials: MA
authors.lastname: Carranza
authors.forename: Rodger
authors.initials: R
authors.lastname: Elble
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D023381:Endpoint Determination; D020329:Essential Tremor / Q000188:drug therapy* / Q000503:physiopathology; D018757:GABA Modulators / Q000627:therapeutic use*; D006801:Humans; D000069583:Pregabalin; D011446:Prospective Studies; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018757:GABA Modulators; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid